ARAY

Accuray Incorporated

0.23

USD

-0.01

-2.90%

Sep 18, 14:03 UTC -4

Open

Accuray Incorporated Profile

About

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.

Info & Links

CEO

Steve La Neve

Headquarters

1240 Deming Way
MADISON, WI 53717, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

115

Employees

809

Accuray Incorporated Statistics

Valuation Measures

Market Capitalization²

27.95M

Enterprise Value

134.58M

Enterprise Value/EBITDA(ttm)

-12.93

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.07

Price to Book(mrq)

0.66

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

27.79%

Operating Margin(ttm)

-12.09%

Profit Margin(ttm)

-12.43%

Return on Equity(ttm)

-97.85%

Return on Invested Capital(ttm)

-26.94%

Return on Assets(ttm)

-10.82%

Income Statement

Revenue(ttm)

401.95M

Revenue Per Share(ttm)

3.37

Gross Profit(ttm)

111.45M

EBITDA(ttm)³

-10.41M

Net Income Available to Common(ttm)

-49.19M

Diluted EPS(ttm)

-0.40

Share Statistics

Beta (5Y Monthly)

1.39

52-Week Change

-85.28%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

119.44M

Dividend Yield

0.00%

Float⁴

116.57M

% Held by Insiders

2.40%

% Held by Institutions

64.08%

Balance Sheet

Total Cash(mrq)

41.23M

Total Cash Per Share(mrq)

0.35

Total Debt(mrq)

147.87M

Total Debt/Equity(mrq)

354.61%

Current Ratio(mrq)

1.50%

Quick Ratio(mrq)

0.74%

Book Value Per Share(mrq)

0.35

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.06

Free Cash Flow(ytd)

-12.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.